AUROBINDO PHARMA LTD.

Report DateResearch houseDescriptionRecoAt PriceTarget PriceUpSide
/DownSide
Download
12-Nov-20 Isec In line numbers with better gross margins… Buy 850 1025 20.6
27-Sep-20 Motilal Oswal Development of complex pipeline on track Buy 772 1030 33.4
13-Aug-20 Isec In line numbers; US steady despite injectables drop Buy 896 1100 22.8
21-Apr-20 Isec Unit IV receives VAI status from USFDA at last… Buy 632 770 21.8
11-Mar-20 Motilal Oswal Observations at Unit 12 resolvable on robust CAPA Buy 450 530 17.78


Analyst Calls / Meets


Management Interviews

No Management Interviews.

Investor Presentations

12-Nov-20 Investor/Anal...
13-Aug-20 Investor/Anal...
03-Jun-20 Investor/Anal...
06-Feb-20 Investor/Anal...
14-Jan-20 Investor/Anal...

Annual Reports
Source: Reportjunction.com

2019-20  
2018-19  
2017-18  
2016-17  
2015-16  

Research Showcase

12-Nov-20
Isec - Quarter ..
Download
27-Sep-20
Motilal Oswal -..
Download
13-Aug-20
Isec - Quarter ..
Download
21-Apr-20
Isec - Company ..
Download
11-Mar-20
Motilal Oswal -..
Download

Results

03-Jun-20 Results
06-Feb-20 Results
13-Nov-19 Results
13-Nov-19 Results
07-Aug-19 Results

AGM/EGM/Board Meetings

12-Aug-20 - Quarterly Results & In..
03-Jun-20 - Aurobindo Pharm Ltd
12-Nov-19 - Quarterly Results & In..
07-Aug-19 - Quarterly Results
28-May-19 - Audited Results

Press Release

24-Dec-20 Press Release
09-Dec-20 Press Release
22-Oct-20 Press Release
04-May-20 Press Release
09-Apr-20 Press Release

 

Archived Documents